Biological function of UCA1 in hepatocellular carcinoma and its clinical significance: Investigation with in vitro and meta-analysis.
暂无分享,去创建一个
Ping Li | Hong Yang | Peng Lin | Gang Chen | Yun He | L. Qin | Hong Yang | Gang Chen | R. Tang | Ping Li | D. Luo | Yun He | P. Lin | Dian-Zhong Luo | Li-Ting Qin | Rui-Xue Tang | Qing Li | Qing Li
[1] W. Qiang,et al. Silencing of Urothelial Carcinoma Associated 1 Inhibits the Proliferation and Migration of Medulloblastoma Cells , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[2] J. Emond,et al. Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma , 2018, Journal of hepatocellular carcinoma.
[3] C. Sirlin,et al. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis , 2017, Abdominal Radiology.
[4] Hirokazu Takahashi,et al. Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods , 2017, Journal of Gastroenterology.
[5] Zhihong Li,et al. Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets , 2017, Cellular Physiology and Biochemistry.
[6] Jixiang Wu,et al. Clinicopathological and prognostic significance of OCT4 in patients with hepatocellular carcinoma: a meta-analysis , 2017, OncoTargets and therapy.
[7] Hong Yang,et al. Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study , 2016, Cancer Cell International.
[8] Gang Chen,et al. The clinical value of miR‐193a‐3p in non‐small cell lung cancer and its potential molecular mechanism explored in silico using RNA‐sequencing and microarray data , 2018, FEBS open bio.
[9] Gang Chen,et al. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study. , 2017, Pathology, research and practice.
[10] P. Burra,et al. Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma , 2018, Cancers.
[11] Huan Pang,et al. LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway , 2017, Cellular Physiology and Biochemistry.
[12] Zhen-bo Feng,et al. The essential role of MTDH in the progression of HCC: a study with immunohistochemistry, TCGA, meta-analysis and in vitro investigation. , 2017, American journal of translational research.
[13] Long-Bang Chen,et al. The Emerging Roles of Long Noncoding RNA ROR (lincRNA-ROR) and its Possible Mechanisms in Human Cancers , 2016, Cellular Physiology and Biochemistry.
[14] D. Samuel,et al. The impact of treatment of hepatitis C with DAAs on the occurrence of HCC , 2018, Liver international : official journal of the International Association for the Study of the Liver.
[15] Yu-qin Pan,et al. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway , 2015, Oncotarget.
[16] Wei Li,et al. Liver transplantation vs liver resection in patients with HBV‐related hepatocellular carcinoma beyond Milan criterion: A meta‐analysis , 2018, Clinical transplantation.
[17] Yi-huan Luo,et al. High expression of long non‑coding HOTAIR correlated with hepatocarcinogenesis and metastasis. , 2017, Molecular medicine reports.
[18] Xi-Zhong Shen,et al. The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action. , 2017, Cancer letters.
[19] D. Dalela,et al. Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder , 2014, Tumor Biology.
[20] Xin Tang,et al. Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop , 2016, Tumor Biology.
[21] Jin-hua Jiang,et al. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression , 2017, Journal of Cancer Research and Clinical Oncology.
[22] R. Santella,et al. Exploration of Deregulated Long Non-Coding RNAs in Association with Hepatocarcinogenesis and Survival , 2015, Cancers.
[23] Yang Xiao,et al. HIF-1α-induced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway , 2018, Oncology reports.
[24] Gang Chen,et al. Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients. , 2015, International journal of clinical and experimental pathology.
[25] Sen Lu,et al. HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling , 2016, Scientific Reports.
[26] Guohui Li,et al. Long non‐coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma , 2017, Life sciences.
[27] Bing Li,et al. LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p. , 2016, Cancer letters.
[28] Gang Chen,et al. The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model , 2017, BMC Cancer.
[29] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[30] Yuemei Hu,et al. Clinical significance of urothelial carcinoma associated 1 in colon cancer. , 2015, International journal of clinical and experimental medicine.
[31] Hong Yang,et al. Diagnostic value of strand‐specific miRNA‐101‐3p and miRNA‐101‐5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action , 2017, FEBS open bio.
[32] Y. Dang,et al. Comprehensive analysis of long non-coding RNA PVT1 gene interaction regulatory network in hepatocellular carcinoma using gene microarray and bioinformatics. , 2017, American journal of translational research.
[33] Zhen-bo Feng,et al. Clinicopathological significance of STAT4 in hepatocellular carcinoma and its effect on cell growth and apoptosis , 2016, OncoTargets and therapy.
[34] I. Umelo,et al. miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells , 2013, PloS one.
[35] Hong Yang,et al. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma , 2018, BMC Cancer.
[36] Tongyu Ji,et al. Long non-coding RNA UCA1 promotes cell progression by acting as a competing endogenous RNA of ATF2 in prostate cancer. , 2017, American journal of translational research.
[37] M. Matboli,et al. Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma , 2016, Expert review of gastroenterology & hepatology.
[38] Chen Li,et al. Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer , 2017, Cell Death & Disease.
[39] F. Zhou,et al. T Cell–Associated Immunotherapy for Hepatocellular Carcinoma , 2017, Cellular Physiology and Biochemistry.
[40] P. Marcellin,et al. Liver diseases: A major, neglected global public health problem requiring urgent actions and large‐scale screening , 2018, Liver international : official journal of the International Association for the Study of the Liver.
[41] C. Park,et al. HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus , 2015, Disease markers.
[42] M. Sallam,et al. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma. , 2016, Translational research : the journal of laboratory and clinical medicine.
[43] Zhen-bo Feng,et al. Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma. , 2015, Oncology reports.
[44] L. Ming,et al. Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma , 2017, Cellular Physiology and Biochemistry.
[45] Shangqi Yang,et al. LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway. , 2017, Oncology letters.
[46] Zhen-bo Feng,et al. Long non-coding RNA HOTTIP promotes hepatocellular carcinoma tumorigenesis and development: A comprehensive investigation based on bioinformatics, qRT-PCR and meta-analysis of 393 cases , 2017, International journal of oncology.
[47] Wen-Chao Liu,et al. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma , 2017, The Journal of international medical research.
[48] G. Halder,et al. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment , 2013, Nature Reviews Drug Discovery.
[49] S. Diederichs,et al. Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets. , 2017, Journal of hepatology.
[50] Yi-huan Luo,et al. MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1. , 2015, International journal of clinical and experimental pathology.
[51] Zhenggang Zhu,et al. Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer. , 2017, Cancer letters.